17,261 trials
Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Primary Peritoneal Carcinoma
Primary: Percentage of Patients With a Confirmed Tumor Response, Defined as Complete Response or Partial Response Estimated Using Response Evaluation Criteria in Solid Tumors 1.1…
Non Small Cell Lung Cancer
Primary: Progression Free Survival — 77.1 percentage of participants
Heart Failure · Hypertension, Pulmonary
Primary: Maximal Knee Extensor Power — 4.20; 4.74 W/kg — p=0.0153
Non-small Cell Lung Cancer, NSCLC
Primary: Progression-Free Survival (PFS) — 19 Participants
Non-alcoholic Steatohepatitis (NASH)
Primary: Improvement (Yes/ no) From Baseline in Liver Histological Findings Based on Liver Biopsy After 48 Weeks of Treatment in Patients With NASH (NAS ≥ 4, Fibrosis F1-F3)…
B-Cell Non-Hodgkin Lymphoma · Hematopoietic and Lymphoid Cell Neoplasm · Leukemia
Primary: Number of Participants Experienced Severe Toxicity From Lenalidomide and Ipilimumab Post Transplant — 10; 2 Participants
Triple Negative Breast Cancer
Primary: Percent Change in the Peripheral Immunoscore (PIS) at Week 6 — 30.63; -21.9; 32.285 % Change in PIS
Multiple Myeloma
Primary: Rate of Stringent Complete Response — 1 Participants
Alcohol Use Disorder · Alcohol Drinking · Alcohol Use Disorder (AUD)
Primary: Alcohol Craving — 6.44; 6.26 score on a scale — p=0.784
Type 1 Diabetes Mellitus With Hypoglycemia
Primary: Incidence of All AEs in Cohort 1 Participants — 33; 2; 24; 8 Adverse Events
Smoking Cessation
Primary: Number of Participants Abstinent From Vaping at Week 8 — 9; 6 Participants
Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
Primary: Change From Baseline in Negative Emotional Bias in the Facial Expression Recognition Task (FERT) — 8.1316; 13.6138; 8.0168; 6.7407 Percent change — p=0.0479
Central Retinal Vein Occlusion
Primary: Incidence and Severity of Ocular and Systemic Adverse Events — 1; 0; 0; 1 participants
Cancer Pain
Primary: To Compare the Time to Readiness for Discharge From PACU (Minutes) After Port-a-Cath Placement Surgery Between Patients Who Are Randomized to Receive Intraoperative…
Alzheimer Disease
Primary: Number of TEAEs, Related TEAEs, SAEs, and Related SAEs — 6; 11; 4; 7 Participants